» Articles » PMID: 37956206

Bayesian Spatial Modelling of Localised SARS-CoV-2 Transmission Through Mobility Networks Across England

Overview
Specialty Biology
Date 2023 Nov 13
PMID 37956206
Authors
Affiliations
Soon will be listed here.
Abstract

In the early phases of growth, resurgent epidemic waves of SARS-CoV-2 incidence have been characterised by localised outbreaks. Therefore, understanding the geographic dispersion of emerging variants at the start of an outbreak is key for situational public health awareness. Using telecoms data, we derived mobility networks describing the movement patterns between local authorities in England, which we have used to inform the spatial structure of a Bayesian BYM2 model. Surge testing interventions can result in spatio-temporal sampling bias, and we account for this by extending the BYM2 model to include a random effect for each timepoint in a given area. Simulated-scenario modelling and real-world analyses of each variant that became dominant in England were conducted using our BYM2 model at local authority level in England. Simulated datasets were created using a stochastic metapopulation model, with the transmission rates between different areas parameterised using telecoms mobility data. Different scenarios were constructed to reproduce real-world spatial dispersion patterns that could prove challenging to inference, and we used these scenarios to understand the performance characteristics of the BYM2 model. The model performed better than unadjusted test positivity in all the simulation-scenarios, and in particular when sample sizes were small, or data was missing for geographical areas. Through the analyses of emerging variant transmission across England, we found a reduction in the early growth phase geographic clustering of later dominant variants as England became more interconnected from early 2022 and public health interventions were reduced. We have also shown the recent increased geographic spread and dominance of variants with similar mutations in the receptor binding domain, which may be indicative of convergent evolution of SARS-CoV-2 variants.

Citing Articles

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among Children attending the Pediatric Hospital in Bamako, Mali (BamaCoV-Kids Study).

Maiga A, Kodio A, Ouedrago S, Balde A, Dembele P, Traore F Res Sq. 2024; .

PMID: 39399663 PMC: 11469376. DOI: 10.21203/rs.3.rs-4983012/v1.


The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England.

Ward T, Fyles M, Glaser A, Paton R, Ferguson W, Overton C Nat Commun. 2024; 15(1):4633.

PMID: 38821930 PMC: 11143367. DOI: 10.1038/s41467-024-47199-3.

References
1.
Lemey P, Ruktanonchai N, Hong S, Colizza V, Poletto C, Van den Broeck F . Untangling introductions and persistence in COVID-19 resurgence in Europe. Nature. 2021; 595(7869):713-717. PMC: 8324533. DOI: 10.1038/s41586-021-03754-2. View

2.
Cao Y, Jian F, Yu Y, Song W, Yisimayi A, Wang J . Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2022; 614(7948):521-529. PMC: 9931576. DOI: 10.1038/s41586-022-05644-7. View

3.
Chang S, Pierson E, Koh P, Gerardin J, Redbird B, Grusky D . Mobility network models of COVID-19 explain inequities and inform reopening. Nature. 2020; 589(7840):82-87. DOI: 10.1038/s41586-020-2923-3. View

4.
Panigutti C, Tizzoni M, Bajardi P, Smoreda Z, Colizza V . Assessing the use of mobile phone data to describe recurrent mobility patterns in spatial epidemic models. R Soc Open Sci. 2017; 4(5):160950. PMC: 5451791. DOI: 10.1098/rsos.160950. View

5.
Singh J, Rahman S, Ehtesham N, Hira S, Hasnain S . SARS-CoV-2 variants of concern are emerging in India. Nat Med. 2021; 27(7):1131-1133. DOI: 10.1038/s41591-021-01397-4. View